MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Revenue
$26K
Net Income
-$3,284K
Net Profit Margin
-12630.77%
EPS
$1.57
Unit: Thousand (K) dollars
Revenue Breakdown
Clinical treatment programs - us
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-09-30
2025-06-30
2025-03-31
Total revenues
26
25
16
Production costs
68
10
10
Research and development
607
1,174
1,080
General and administrative
1,798
1,487
2,545
Total costs and expenses
2,473
2,671
3,635
Operating loss
-2,447
-2,646
-3,619
Gain (loss) on investments
-1
-9
27
Interest and other income
3,052
10
11
Interest expense and other finance costs
148
149
124
Issuance cost
433
-
-
Loss on issuance of warrants
-3,977
0
-
Change in fair value of warrants
-670
-
-
Net loss
-3,284
-2,794
-3,705
Basic EPS
1.57
-3.68
-0.05
Diluted EPS
1.57
-3.68
-0.05
Basic Average Shares
2,093,446
759,289
70,329,869
Diluted Average Shares
2,093,446
759,289
70,329,869
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
AIMI Income Statement Sankey Diagram
Sankey diagram visualizing AIMI income statement for the period
Net loss
-$3,284K
Interest and other income
$3,052K
Change in fair value of
warrants
-$670K
Clinical treatment
programs - us
$26K
Loss on issuance of
warrants
-$3,977K
Operating loss
-$2,447K
Total revenues
$26K
Issuance cost
$433K
Interest expense and
other finance costs
$148K
Gain (loss) on
investments
-$1K
Total costs and
expenses
$2,473K
General and
administrative
$1,798K
Research and development
$607K
Production costs
$68K
Buy us a coffee
AIM ImmunoTech Inc. (AIMI)
AIM ImmunoTech Inc. (AIMI)